ORIGINAL RESEARCH
Published on 01 Jul 2026
Safety and preliminary efficacy of Disitamab Vedotin combined with Toripalimab and concurrent radiotherapy in bladder-preserving treatment for HER2-positive invasive bladder cancer
doi 10.3389/fonc.2026.1880457
- 1,164 views
